Exclusives

A retrospective chart review of 294 hospitalized patients with moderate to severe diabetic foot infections (DFIs) found that re-infection is common. Key risk factors include osteomyelitis, non-healing wounds, prolonged wound healing, use of...

Avita announced the US FDA has approved its premarket approval (PMA) supplement for RECELL GO mini, a disposable cartridge designed specifically to treat smaller wounds up to 480 sq cm, compared to the standard RECELL GO disposable cartridge,...

Avita Medical announced that the US FDA has granted 510(k) clearance for Cohealyx, a new collagen-based dermal matrix for full-thickness wounds. Branded by Avita Medical and co-developed with Regenity Biosciences, the company expects a US...

Medline announced it has confidentially submitted a draft registration statement on Form S-1 to the US Securities and Exchange Commission (SEC) relating to the proposed initial public offering of its common stock. Shares to be offered and...

A 378-patient comparison study of 3 skin substitutes (EZ-Derm, Surprathel and Biobrane) for treatment of pediatric burns found Suprathel was associated with a shorter hospital stay, lower need for escharotomy and grafting, and lower LT...

BioTissue noted that with the company’s strong focus on the high-growth ocular business, BioTissue is looking for partners for its surgical, wound and ortho product lines, which it reports has $33MM+ in revenue with EBITDA breakeven targeted...

A retro cohort of 61 patients with mesh infections from hernia repair found NPWT was an effective method for salvaging infected meshes, with a success rate of 80%. Active smoking was a risk factor for failure, highlighting the need for early...

According to a 106-patient multicenter observational study in India, DACC-impregnated dressings effectively reduced SSIs in post-op care for ortho and gastrointestinal surgeries, particularly beneficial in reducing the risks associated with...

A meta-analysis assessing healing rates of DFUs using SoC found a pooled healing rate of 33.1% with an average healing time of 50.1 days. Findings highlight the need for advanced care strategies, personalized treatment plans to improve...

A 50-patient RCT will examine the use of NPWT vs SoC for the treatment of patients with DFUs with primary outcome being the number of lower extremity amputations up to 1 year. Not yet recruiting; the estimated study completion is Dec 2028....